DrugPatentWatch Database Preview
Casi Pharms Inc Company Profile
What is the competitive landscape for CASI PHARMS INC, and what generic and branded alternatives to CASI PHARMS INC drugs are available?
CASI PHARMS INC has twenty-six approved drugs.
Summary for Casi Pharms Inc
| US Patents: | 0 |
| Tradenames: | 24 |
| Ingredients: | 24 |
| NDAs: | 26 |
Drugs and US Patents for Casi Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Casi Pharms Inc | LISINOPRIL | lisinopril | TABLET;ORAL | 075994-004 | Jul 1, 2002 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Casi Pharms Inc | ECONAZOLE NITRATE | econazole nitrate | CREAM;TOPICAL | 076075-001 | Nov 26, 2002 | DISCN | No | No | See Pricing | See Pricing | |||||
| Casi Pharms Inc | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | TABLET;ORAL | 077517-003 | Jun 25, 2007 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Casi Pharms Inc | BENAZEPRIL HYDROCHLORIDE | benazepril hydrochloride | TABLET;ORAL | 076402-004 | Feb 11, 2004 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Casi Pharms Inc | NARATRIPTAN | naratriptan hydrochloride | TABLET;ORAL | 090288-001 | Jul 7, 2010 | DISCN | No | No | See Pricing | See Pricing | |||||
| Casi Pharms Inc | BISOPROLOL FUMARATE | bisoprolol fumarate | TABLET;ORAL | 075643-002 | Nov 16, 2000 | AB | RX | No | No | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
